Plunkett Research Online: Swedish Orphan Biovitrum AB

SWEDISH ORPHAN BIOVITRUM AB (SWTUY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Swedish Orphan Biovitrum AB (Sobi) is an integrated biopharmaceutical company that provides and develops specialty pharmaceuticals for rare diseases. Its key therapeutic areas include haemophilia and specialty care. Haemophilia is a type of bleeding disorder in which the blood does not clot proper.....



Swedish Orphan Biovitrum AB
Ticker: SWTUY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 46 86972000
Fax: 46 86972330
Address: Tomtebodavagen 23 A
Solna
Stockholm, SE-112 76 Sweden

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

Guido OelkersCEO
Mats-Olof WallinVP-CFO
See More
Swedish Orphan Biovitrum AB (Sobi) is an integrated biopharmaceutical company that provides and develops specialty pharmaceuticals for rare diseases. Its key therapeutic areas include haemophilia and specialty care. Haemophilia is a type of bleeding disorder in which the blood does not clot proper.....See More See More

Auditor: Ernst & Young AB
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Ammonaps
Fositen
Kineret
Pexsig
Succicaptal
Xiapex
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: